JSE LIMITED (Incorporated in the Republic of South Africa) Registration number: 2005/022939/06 Share Code: JSE ISIN: ZAE000079711 LEI: 213800MZ1VUQEBWRFO39 (“JSE”) DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY SECRETARY AND THE JSE LTIS 2018 TRUST The JSE LTIS 2018 Trust (“Trust”) has acquired 756 828 JSE ordinary shares in the open market on behalf of executive directors, prescribed officers, the Company Secretary, and senior members of staff (“LTIS 2018 participants”) in respect of share awards granted in March 2023 to these LTIS 2018 participants under the JSE’s Long-Term Incentive Scheme (“LTIS 2018”). The ordinary shares are held by the LTIS 2018 participants on a direct beneficial basis. These ordinary shares are restricted until all vesting criteria are fulfilled whereupon the shares will vest in the hands of LTIS 2018 participants. To the extent that the vesting criteria are not fulfilled, the share awards are forfeited. The vesting of these restricted JSE ordinary shares is subject to – (i) the JSE achieving specified corporate performance targets over the measurement period; and (ii) the LTIS 2018 participant remaining in the employ of the JSE for the vesting term (collectively “the vesting criteria”). These JSE ordinary shares were acquired on-market, with prior clearance and at a volume-weighted average price (“VWAP”) of R104.726625 per ordinary share. The total transaction value amounted to R79 260 042. The daily high, low and volume-weighted average price for the various transactions effected by the Trust were – Dates in 2023 Daily VWAP of Number of JSE Daily highest Daily lowest that JSE JSE shares ordinary price paid price paid ordinary acquired shares (cents per (cents per shares were (cents per acquired share) share) acquired share) 15 March 77 861 10298.89 10310 10180 16 March 678 967 10492.59 10500 10377 The requisite approvals have been granted by shareholders at the JSE’s annual general meeting, in respect of the acquisition of JSE ordinary shares in the open market and in respect of specific financial assistance to the Trust for the purpose of acquiring these ordinary shares. ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY Following the acquisition of the JSE ordinary shares by the Trust as disclosed above, the executive directors, the prescribed officers and the Company Secretary have, on 20 March 2023, accepted grants of restricted JSE ordinary shares, as reflected below. Total number Total Rand value of restricted of restricted JSE JSE ordinary Nature of Executive Role ordinary shares shares interest awarded and awarded and accepted accepted Group CEO & Direct L Fourie Executive 125 468 13 139 840 beneficial Director Group CFO & Direct F Suliman Executive 54 892 5 748 653 beneficial Director Prescribed Direct A Greenwood 54 892 5 748 653 Officer beneficial Prescribed Direct V Lee 29 214 3 059 483 Officer beneficial Prescribed Direct I Monale 40 711 4 263 525 Officer beneficial Prescribed Direct Q Mthembu 19 029 1 992 842 Officer beneficial Prescribed Direct M Randall 46 192 4 837 532 Officer beneficial Prescribed Direct T Tsoaeli 41 169 4 311 490 Officer beneficial Prescribed Direct V Reddy 60 991 6 387 381 Officer beneficial Group Company Direct GA Brookes 13 794 1 444 599 Secretary beneficial The restricted shares will vest in two tranches, one-half on 1 March 2026 and the remaining half on 1 March 2027, subject to the vesting criteria as set out above being met. The individual allocations (grant and acceptance) were approved by the JSE’s Group Remuneration Committee and clearance to deal was granted by the Chairman of the Board. Sandton 20 March 2023 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited)